^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ROR1.TNK

    i
    Other names: ROR1.TNK, ROR1 CAR.TNK, chimeric antigen receptor tumour attacking Neukoplast cell therapy
    Associations
    News
    Trials
    Company:
    ImmunityBio, Sorrento
    Drug class:
    ROR1 inhibitor
    Related drugs:
    Associations
    News
    Trials